Hospitals, clinics and other users of Hospira Inc.'s Symbiq infusion pumps have been asked to pull the plug on the systems or update them with a temporary patch. This comes as the firm transitions to newer, safer pumps because the system was discovered to be vulnerable to cybersecurity attacks that could put patient lives at risk.
FDA issued a safety communication to the public July 31 warning against the use of Symbiq and urging users to immediately cease using the device (if possible) in order to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?